People · Operator

Sieradzki Krindel Yaffa

Named in public records as an officer, director or promoter · active 2019–2019 · Healthtech

1
Companies
1
Filings
$14.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Itamar Medical Ltd.HealthtechSeries A$14.7M$331.4M2019
Operator network

Sieradzki Krindel Yaffa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Giora Yaron · 2 companies · 1 sharedGiora YaronJonathan Kolber · 2 companies · 1 sharedJonathan KolberSami Totah · 2 companies · 1 sharedSami TotahShy Basson · 2 companies · 1 sharedShy BassonChristopher M. Cleary · 1 companies · 1 sharedChristopher M. Cl…Efrat Litman · 1 companies · 1 sharedEfrat LitmanEilon Livne · 1 companies · 1 sharedEilon LivneGilad Glick · 1 companies · 1 sharedGilad GlickIlan Biran · 1 companies · 1 sharedIlan BiranItay Kariv · 1 companies · 1 sharedItay KarivJacob (Koby) Sheffy · 1 companies · 1 sharedJacob (Koby) Shef…Martin Gerstel · 1 companies · 1 sharedMartin GerstelShlomo Ayanot · 1 companies · 1 sharedShlomo AyanotZipora (Tzipi) Krindel Ozer-Armon · 1 companies · 1 sharedZipora (Tzipi) Kr…Itamar Medical Ltd. · $14.7M raisedItamar Medical Ltd.Sieradzki Krindel YaffaSY
Sieradzki Krindel Yaffa Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Sieradzki Krindel Yaffa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jonathan Kolber12
Shy Basson12
Sami Totah12
Giora Yaron12
Ilan Biran11
Efrat Litman11
Jacob (Koby) Sheffy11
Shlomo Ayanot11
Eilon Livne11
Christopher M. Cleary11
Martin Gerstel11
Itay Kariv11
Gilad Glick11
Zipora (Tzipi) Krindel Ozer-Armon11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.